10 habits that will make you happier than 98% of people:

🚨 Is non-fasting before coronary intervention safe? Check out the results of the TONIC trial in this new issue of #JACCINT: bit.ly/3KmLAqg

Writing a scientific article: A Step-by-Step Guide for Beginners (1/7)

Giving #CPR and using an AED within the first few minutes of sudden cardiac arrest can greatly improve a person's chances of survival. Help your patients understand SCA with this #CardioSmart infographic 👇 bit.ly/3qzufng #ACCAthleticHeart #SportsCardio

🔥Fresh Press 🔥 We propose a novel candidate therapy for HFpEF. doi.org/10.1002/ejhf.3… Sanjiv J. Shah, MD Sheldon Litwin Kavita Sharma Mikhail Kosiborod Saint Luke's Mid America Heart Institute Saint Luke's

Gave a talk at ASNC2024 Annual Scientific Session and Exhibition on Incidental Uptake Finding in TC-99M Sestamibi Myocardial Perfusion Imaging for Multiple Myeloma. Thanks for the great turnout! #ASNC2024 #CVNuc #THINKPET - via #Whova event #MyASNC ⁦Brett Sperry, MD⁩

Write a research paper this weekend! Use my mini-guide:⬇️

🎉 Exciting Announcement! 🎉 We are delighted to share the Creighton University Cardiovascular Disease Fellowship 2024-2025 Match Results 💙💛 #CreightonCardiology #InterventionalCardiology #FellowshipClass2028 #CardiovascularExcellence #WelcomeToCreighton

Does STEMI Need a Rebrand to ‘Occlusion MI’? Drs. Robert Harrington Manesh Patel and I discuss medscape.com/viewarticle/10… via @medscape

Do we need to move away from the classification of ST Elevation MI (STEMI) to Occluded vessel MI (OMI) ? Why or why not?

Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public. Nothing else is even close.

Tobacco smoking from ages 10 to 24 years was associated with a 33% to 52% odds of premature structural and functional cardiac injury, according to a 🆕 study published in #JACC. Read more: bit.ly/4fglySu #cvPrev JACC Journals

Obesity and Glucagon-Like Peptide-1 Receptor Agonists | Obesity | JAMA | JAMA Network Important opinion on the dichotomy of obesity and the trends in GLP-1RA prescription and way forward. ⁦Inova Schar Heart and Vascular⁩ jamanetwork.com/journals/jama/…

The SUMMIT trial showed that among obese patients w/ #HFpEF, once weekly subcutaneous tirzepatide was superior to placebo in improving the composite endpoint of CV death & HF-related events over 104 weeks of follow-up. Read latest updates here: bit.ly/49PPl3A #cvPrev

Excited to welcome our new class of IM residents! Congratulations and we can't wait to see you all! 🎉 #Match2025

1/2: For the past 10 years we’ve helped all cardiology fellows start! Here we go again. Join us virtually back to back Saturdays July 19 & 26 - 8 am to 1 pm! Faculty in 2/2 below Babar Basir Carlos L. Alviar MD, FACC Jason N. Katz Anna Bortnick MD, PhD, MSc Sahil Khera Anu Lala-Trindade Felix Yang, MD, FACC, FHRS

🚨 Hot off the press: JACC Advances SGLT2i ↓ myocardial glucose uptake on FDG-PET: ▪️ 374-pt matched cohort ▪️ “No uptake” in 65 % on SGLT2i vs 37 % controls ▪️ Total myocardial glycolysis ⬇️ despite ↑ prescan glucose Metabolic shift may underlie CV benefits & carries

Proud to contribute to this new JACC: Advances study led by Brett Sperry, MD 📊 SGLT2i therapy is linked to markedly lower myocardial glucose uptake on FDG-PET — suggesting a metabolic shift that may explain CV benefits. Ramy Ghaly, MD, MS doi.org/10.1016/j.jaca…

Grateful for dedicated mentors like Dr. Haddad who continuously inspire and guide our fellows. Excellence in education starts with great leadership. 🫀 #Cardiology

Dopamine in Cardiogenic Shock: A Silent Start? In this letter, we explored dopamine use in CS, a long-debated inotrope that may still have a place. accjournal.org/journal/view.p… Amr Salah Omar #ACCjournal